Timely Treatment and No Change in Thyroid Cancer Mortality During COVID-19 Pandemic. Reply to Nocini et al. No Impact of COVID-19 Pandemic on Early Mortality for Thyroid Cancer in the US. Comment on "Lee et al. Impact of the COVID-19 Pandemic on Thyroid Cancer Surgery. Curr. Oncol. 2024, 31, 3579-3590".

IF 2.8 4区医学 Q2 ONCOLOGY

Current oncology Pub Date : 2024-10-17 DOI:10.3390/curroncol31100467

Max L Lee, Michelle M Chen

引用次数: 0

Abstract

We thank Nocini et al [...].

查看原文本刊更多论文

COVID-19大流行期间及时治疗和甲状腺癌死亡率无变化。回复 Nocini 等：《COVID-19 大流行对美国甲状腺癌早期死亡率无影响》。对 "Lee等：COVID-19大流行对甲状腺癌手术的影响 "的评论。Curr.Oncol.2024, 31, 3579-3590".

我们感谢 Nocini 等人[......]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current oncology ONCOLOGY-

CiteScore

3.30

自引率

7.70%

发文量

664

审稿时长

1 months

期刊介绍： Current Oncology is a peer-reviewed, Canadian-based and internationally respected journal. Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy in Canada to report upon and to review progress in the management of this disease. We encourage submissions from all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.